EFFECT OF RALOXIFENE IN THE PREVENTION OF OSTEOPOROSIS OF ALVEOLAR BONE INDUCED BY HIGH FAT DIET IN RATS

Authors

1 Demonstrator of Oral Biology, Faculty of dentistry, Pharos University

2 Professor of oral biology, Faculty of Dentistry, Alexandria University.

3 Lecturer, Department of Oral Biology, Faculty of Dentistry, Alexandria University

4 Lecturer of animal production (nutrition), Faculty of Agriculture, Alexandria University.

Abstract

INTRODUCTION: Obesity is positively associated with many chronic disorders such as osteoporosis, as it decreases the osteoblastic cell formation, increases the osteoclastic activity and decreases the vascularity of the bone marrow as well. Raloxifene belongs to a class of drugs called selective estrogen receptor modulators (SERMs). It reduces the expression of bone turnover markers and increases bone mineral density. OBJECTIVES: To investigate the effect of Raloxifene in the prevention of osteoporosis of alveolar bone induced by high fat diet in the rats.\ MATERIALS AND METHODS Thirty female albino rats were divided randomly into 3 equal groups, (10 rats each) as follows: Group I: control group, Group II: High fat diet group (59.28% of fats in their chow), Group III: High fat diet group (59.28%) with intake of Raloxifene 1mg/ kg once daily for 12 weeks. After 12 weeks all rats were sacrificed, molar segments of the mandibles were dissected and prepared for histological and histomorphometric analysis. RESULTS: In high fat diet group, there was a significant deterioration in alveolar bone architecture and decrease in its surface area. Bone surface became irregular with multiple osteoclasts. It consisted of thin trabeculae enclosing wide fatty infiltrated bone marrow. In the high fat diet group treated with Raloxifene the alveolar bone surface and architecture relatively returned back to the normal. The histomorphometric results, revealed a significant decrease in the total bone surface area in high fat diet group and a significant restoration of the bone surface area in high fat diet group treated with Raloxifene in relation to control group. CONCLUSIONS: High fat diet can induce alveolar bone osteoporosis and Raloxifene is an effective drug in restoring alveolar bone density and architecture

Keywords

Main Subjects

References

  1. Kanis JA, McCloskey EV, Harvey NC, Johansson H, Leslie WD. Intervention thresholds and the diagnosis of osteoporosis. Journal of Bone and Mineral Research. 2015 Oct 1;30(10):1747-53.
  2. Riggs BL, Khosla S, Melton LJ. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. Journal of bone and mineral research. 1998;13(5):763-73.
  3. Fitzpatrick LA, editor Secondary causes of osteoporosis. Mayo Clinic Proceedings; 2002: Elsevier.
  4. Golob, AL; Laya, MB . "Osteoporosis: Screening, Prevention, and Management.". The Medical clinics of North America.2015; 99 : 587–606.
  5. Bosello O, Donataccio MP, Cuzzolaro M. Obesity or obesities? Controversies on the association between body mass index and premature mortality. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity. 2016;21(2):165-74.
  6. Roy B, Curtis ME, Fears LS, Nahashon SN, Fentress HM. Molecular mechanisms of obesity-induced osteoporosis and muscle atrophy. Frontiers in physiology. 2016 Sep 29;7:439.
  7. L ee RH, Kim B, Choi I, Kim H, Choi H, Suh K, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cellular Physiology and Biochemistry. 2004;14(4-6):311- 24.
  8. Fantuzzi G. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology. 2005;115(5):911-9.
  9. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007;56(8):1986- 98.
  10. Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y. Oxidative stress in bone remodelling and disease. Trends in molecular medicine. 2009;15(10):468-77.
  11. Liu A-L, Zhang Z-M, Zhu B-F, Liao Z-H, Liu Z. Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Cell biology international. 2004;28(12):905-11.
  12. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100(2):197-207.
  13. Pramojanee S, Kumphune S, Phimphilai M, Chattipakorn N, Chattipakorn SC. Decreased jaw bone density and impaired osteoblastic insulin signaling in obese insulin resistant rats. Bone Biology: Endocrine Society; 2013. p. SUN-211-SUN-.
  14. Jeong, Eun Ju; Liu, Yong; Lin, Huimin; Hu, Ming. "Species- and Disposition Model-Dependent Metabolism of Raloxifene in Gut and Liver: Role of UGT1A10". Drug Metabolism and Disposition. ASPET. 2005;33 : 785–794.
  15. Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochemical and biophysical research communications. 2005;328(3):688-96.
  16. florencio-silva r, sasso gr, sasso-cerri e, simões mj, cerri ps. biology of bone tissue: structure, function, and factors that influence bone cells. biomed research international. 2015;2015.
  17. Lacey D, Timms E, Tan H-L, Kelley M, Dunstan C, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. cell. 1998;93(2):165-76.
  18. Stringhetta-Garcia CT, Singulani MP, Santos LF, Louzada MJ, Nakamune AC, Chaves-Neto AH, Rossi AC, Ervolino E, Dornelles RC. The effects of strength training and raloxifene on bone health in aging ovariectomized rats. Bone. 2016 Apr 1;85:45-54.
  19. Ramalho-Ferreira G, Faverani LP, Momesso GAC, Luvizuto ER, de Oliveira Puttini I, Okamoto R. Effect of antiresorptive drugs in the alveolar bone healing. A histometric and immunohistochemical study in ovariectomized rats. Clinical Oral Investigations. 2016:1- 10.
  20. Sookvanichsilp N, Tad-urai N, Lawtong P, Sittithumcharee G. Effects of Antiresorptive Drugs on Long Bone Growth, Body Weight Gain, and Serum Lipid Levels in Young Adult Ovariectomized Rats. Mahidol University Journal of Pharmaceutical Sciences. 2014;41(4):29-38.
  21. Ramalho-Ferreira G, Faverani LP, Momesso GAC, Luvizuto ER, de Oliveira Puttini I, Okamoto R. Effect of antiresorptive drugs in the alveolar bone healing. A histometric and immunohistochemical study in ovariectomized rats. Clinical Oral Investigations. 2016:1-10
  22. El-Moneim RAA, El-Mouaty HMA. A comparative histological, immunohistochemical, and biochemical study of the effect of green tea extracts or chromium picolinate administration on the white visceral adipose tissue and liver in albino rats fed on high-fat diet. Egyptian Journal of Histology. 2013;36(4):882-98.
  23. Wauquier F, Leotoing L, Coxam V, Guicheux J, Wittrant Y. Oxidative stress in bone remodelling and disease. Trends in molecular medicine. 2009;15(10):468-77.
  24. Liu A-L, Zhang Z-M, Zhu B-F, Liao Z-H, Liu Z. Metallothionein protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Cell biology international. 2004;28(12):905-11.
  25. Fantuzzi G. Adipose tissue, adipokines, and inflammation. Journal of Allergy and Clinical Immunology. 2005;115(5):911-9.
  26. Patsch JM, Kiefer FW, Varga P, Pail P, Rauner M, Stupphann D, et al. Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet–induced obesity. Metabolism-Clinical and Experimental. 2011;60(2):243-9.
  27. Macri EV, Chaves MMG, Rodriguez PN, Mandalunis P, Zeni S, Lifshitz F, et al. High-fat diets affect energy and bone metabolism in growing rats. European journal of nutrition. 2012;51(4):399-406
  28. Park SB, Kim CH, Hong M, Yang H-J, Chung CK. Effect of a selective estrogen receptor modulator on bone formation in osteoporotic spine fusion using an ovariectomized rat model. The Spine Journal. 2016;16(1):72-81.
  29. Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochemical and biophysical research communications. 2005;328(3):688-96.
  30. Lacey D, Timms E, Tan H-L, Kelley M, Dunstan C, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. cell. 1998;93(2):165-76.
  31. Luvizuto ER, Queiroz TP, Dias SMD, Okamoto T, Dornelles RCM, Garcia Jr IR, et al. Histomorphometric analysis and immunolocalization of RANKL and OPG during the alveolar healing process in female ovariectomized rats treated with oestrogen or raloxifene. archives of oral biology. 2010;55(1):52-9.
  32. Stuermer E, Sehmisch S, Rack T, Wenda E, SeidlovaWuttke D, Tezval M, et al. Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat. Langenbeck's archives of surgery. 2010;395(2):163-72

Files

Share

How to cite

Statistics